Insulin Delivery Devices Market to Reach US$ 22.5 Bn by 2026
Insulin delivery devices are used to deliver insulin to patients with Type 1 and Type 2 diabetes. Insulin is an important part of treatment for the diabetes patient which helps them to get glucose from the bloodstream into the muscle. It cannot be taken as a pill or swallowed liquid because in that way it gets digested and will not reach the bloodstream. As a result, it is injected or infused into the fatty tissues under the skin. Various types of devices are used for the delivery of insulin to the patients including insulin syringe, insulin pens, insulin jet injectors, insulin pumps, and insulin inhalers. Insulin syringes are used for the direct injection of insulin with the help of a needle. Insulin pens are available in the disposable and reusable form with short and thin. Insulin pumps are available in tethered and patch form where the tethered pump is attached with the body with a small tube, whereas the patch pump has no tubes or very short tubes. Additionally, insulin dose is inhaled with the help of insulin inhalers from the mouth, which goes into the lungs later absorbed and passes into the bloodstream and is available in the form of external and implantable insulin in the market.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1636
North America dominated the regional market in 2018 and the region is projected to witness the same pace over the forecast period from 2019 to 2026. The favorable reimbursement policies in the US and Canada, coupled with the increasing FDA approvals to increase the commercial availability of the insulin delivery devices in the country are propelling the regional market growth. In addition, increasing investment in healthcare infrastructure in the region is further accelerating the market value. For instance, Bank of America Corp DE has owned 126,159 shares of Tandem Diabetes Care Inc. stock after buying an additional 30,215 shares in 2019. Bank of America Corp DE has grown its position in the medical company by owning 0.22% of Tandem Diabetes equals US$ 8.14 million.
The insulin pen accounted for the largest market share in the year 2018 owing to the several benefits associated with the usage. It has the ability to accurately pre-set doses using a dial which ultimately saves time and provides on-time dose delivery. They also come with memory features that recall the timing and amount of the previous dose and it comes with a wide range of accessories to allow easy storage and usage. These are the factors accelerating the demand for insulin pen over its alternative segments. For instance, Novo Nordisk partnered with Abbott in 2019 to provide integrated solutions for diabetic patients with the help of insulin pens. This partnership is likely to provide more productive and meaningful outcomes with the optimization of diabetes management.
On the basis of end-use, the homecare segment held the largest market share in 2018 owing to the ease of use and less medical cost. The segment is also expected to witness the maximum market share over the forecast period 2019-2026 because of the increasing awareness among people about the availability of various insulin delivery devices offering convenience and affordability. In addition, the high amount of charges for the treatment imposed by the hospitals is further pushing the individuals to opt homecare solutions.
Some of the leading competitors are Nordisk, Sanofi, Eli Lilly, Medtronic, Insulet, Ypsomed, Becton Dickinson, and others. The companies are involved in research and development activities for providing advance and convenient solutions to diabetes patients. The players were also involved in the mergers and acquisitions for gaining a competitive advantage and also for expanding the market share.
Some of the key observations regarding insulin delivery devices industry include:
- Bigfoot Biomedical partnered with Eli Lilly in 2019 for the development of solutions for optimization of dose delivery with the help of artificial intelligence (AI). The new partnership is heading towards the elevation of the company's position with the introduction of innovative products for diabetes patients.
- Valeritas Holdings, Inc., V-Go Wearable Insulin Delivery device maker has announced and presented the research data at the 19th Annual Diabetes Technology Meeting held in Bethesda, Maryland in 2019. The data shows the positive outcomes for Type 2 diabetes patients who have switched from insulin therapy to V-Go.
- Insulet Corporation has announced the approval of FDA for the use of Fiasp (fast-acting insulin aspart) in 2019. The Fiasp has got the clearance with the Omnipod Insulin Management System and the Omnipod DASH Insulin Management System for adults.
- FDA accelerated the new insulin pump technology with the device approval in February 2019. The new device named Slim X2 insulin pump or an ACE insulin pump is designed to improve automated insulin delivery.
- Abbott and Sanofi have partnered to interconnect their technologies including Abbott’s wearable FreeStyle Libre sensor and Sanofi’s connected insulin pens. The companies are developing software to create a connected device experience for efficient diabetes management.
- Handelsbanken Fonder AB has invested around $3,299,000 in Insulet. Moreover, Insulet Corporation develops, manufactures, and sells insulin delivery systems to diabetes patients.
Market Segment Analysis:
Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of this market.
Market Segmentation
Market By Type
- Insulin Syringe
- Insulin Pens
- Insulin Jet Injectors
- Insulin Pumps
- Insulin Needles
- Insulin Inhalers
Market By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Diabetes Clinics & Centers
Market By End Use
- Hospitals
- Clinics
- Ambulatory Care Centers
- Homecare
Market Regional Analysis:
Based on the regions, the global Insulin Delivery Devices Market is segmented into -North America (US and Canada), Europe (UK, Germany, France, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific), Latin America (Mexico, Brazil and Rest of Latin America), Middle East & Africa (GCC, South Africa and Rest of MEA)
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Insulin Delivery Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Insulin Delivery Devices Market By Type
1.2.2.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Insulin Delivery Devices Market Revenue Share By Type in 2018
1.2.2.3. Insulin Syringe
1.2.2.4. Insulin Pens
1.2.2.5. Insulin Jet Injectors
1.2.2.6. Insulin Pumps
1.2.2.7. Insulin Needles
1.2.2.8. Insulin Inhalers
1.2.3. Insulin Delivery Devices Market By Distribution Channel
1.2.3.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.3.1.1. Hospital Pharmacies
1.2.3.1.2. Retail Pharmacies
1.2.3.1.3. Online Sales
1.2.3.1.4. Diabetes Clinics & Centers
1.2.4. Insulin Delivery Devices Market By End Use
1.2.4.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Clinics
1.2.4.4. Ambulatory Care Centers
1.2.4.5. Homecare
1.2.5. Insulin Delivery Devices Market By Geography
1.2.5.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Insulin Delivery Devices Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Insulin Delivery Devices Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Insulin Delivery Devices Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Insulin Delivery Devices Major Manufacturers in 2018
CHAPTER 4. INSULIN DELIVERY DEVICES MARKET BY TYPE
4.1. Global Insulin Delivery Devices Revenue By Type
4.2. Insulin Syringe
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Insulin Pens
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Insulin Jet Injectors
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Insulin Pumps
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Insulin Needles
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Insulin Needles
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Insulin Inhalers
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. INSULIN DELIVERY DEVICES MARKET BY DISTRIBUTION CHANNEL
5.1. Global Insulin Delivery Devices Revenue By Distribution Channel
5.2. Hospital Pharmacies
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Retail Pharmacies
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Online Sales
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Diabetes Clinics & Centers
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. INSULIN DELIVERY DEVICES MARKET BY END USE
6.1. Global Insulin Delivery Devices Revenue By End Use
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Ambulatory Care Centers
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Homecare
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
7.1. North America Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Insulin Delivery Devices Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE INSULIN DELIVERY DEVICES MARKET BY COUNTRY
8.1. Europe Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
10.1. Latin America Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
11.1. Middle East & AFRICA Insulin Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & AFRICA Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Novo Nordisk
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Sanofi
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Eli Lilly
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medtronic
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Insulet
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Ypsomed
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Becton Dickinson
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Others
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
Contact Here, sales@acumenresearchandconsulting.com | +1 407 915 4157 OR +1 408 900 9135
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1636
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.